Company: PFSA
Filing Date: 2025-08-29
Form Type: S-1
Source: 0001213900-25-082672
Chunk: 129

Company: Profusa, Inc.
Filing Date: 2025-08-29
Form: S-1
Chunk 129
---
 to be used exclusively for the purchase of Bitcoin (which may be used for repayment of indebtedness), provided the Company’s cash balance on any Closing Date exceeds $5,000,000. If the cash balance is less than $5,000,000, proceeds must first be used to bring the cash balance to that amount, with the remainder used to purchase Bitcoin. The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of the Combined Company. They should be read in conjunction with the historical financial statements and notes thereto of NorthView and Profusa. The accompanying pro forma financial statements reflect the impact of transactions that are either completed or considered probable in accordance with Regulation S -XArticle 11. Management has considered the impact of the Committed Equity Facility on these pro forma financial statements, and notes that the agreement is written in a manner in which the Company will issue a variable number of shares at a variable issuance price, based on the then current market rates, less a fixed discount. The number of shares registered to date related to the ELOC facility are expected to be issued, which totals 8,970,830shares. The Company has now started to draw on the ELOC and has estimated the issuance price based on the last actual conversion price, as seen in Tickmark (T) on the unaudited pro forma balance sheet. Pursuant to the Purchase Agreement, 900,000 Commitment Warrant Shares are issuable upon exercise of the Commitment Warrants we issued to Ascent upon our execution of the term sheet relating to the Purchase Agreement on July20, 2025, as consideration for its commitment to purchase shares of our Common Stock that we may, in our sole discretion, direct Ascent to purchase from us pursuant to the Purchase Agreement. The Commitment Warrants have an exercise price of $0.01 and may be exercised for cash or, if at the time of exercise there is no effective registration statement covering the resale of the Commitment Warrant Shares, on a cashless basis. The warrants issued to Ascent are currently being analyzed for their accounting treatment, which the Company expects to be equity classified based on their cashless exercise option. As such, the Company will finalize the accounting conclusions on these warrants, and validate their equity classification for the upcoming September30, 2025 financial statements. As